Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$24.26
+0.160 (+0.664%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Alkermes (ALKS) Up 21.6% Since Last Earnings Report: Can It Continue?

 03:31pm, Friday, 29'th May 2020
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Alkermes To Highlight New Data From Schizophrenia Portfolio At The American Society Of Clinical Psychopharmacology 2020 Annual Meeting

 11:10am, Wednesday, 27'th May 2020

Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting

 11:00am, Wednesday, 27'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced plans to present new research from its schizophrenia portfolio at the American Society of Clinical Psychopharmacology (ASCP) 2020 Annual Meeting, taking pla

Journal of Clinical Psychiatry Publishes Data from Alkermes' ALPINE Study in Patients With Schizophrenia

 11:00am, Wednesday, 20'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced that data from its phase 3b ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation Effectiveness) study were published in the Journal of Clini

Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.

 02:23pm, Monday, 18'th May 2020

Krensavage Asset Management, LLC Buys Alexion Pharmaceuticals Inc, Enanta Pharmaceuticals Inc, ...

 12:00am, Monday, 18'th May 2020

Alkermes To Present New Data From Schizophrenia Portfolio At SIRS Meeting

 11:15am, Thursday, 14'th May 2020

Alkermes Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congress of the Schizophrenia International Research Society

 11:00am, Thursday, 14'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced the presentation of new data from its schizophrenia portfolio as part of the virtual 2020 Congress of the Schizophrenia International Research Society (SIRS

Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $–.– million of Shares

 12:00am, Thursday, 14'th May 2020

Alkermes Announces 'Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA and VIVITROL'

 11:14am, Monday, 11'th May 2020

Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis

 11:00am, Monday, 11'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced the expansion of several programs and services in support of patient access to its proprietary medicines during the COVID-19 crisis. During this unprecedent

Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $7'–,5…… of Shares

 12:00am, Thursday, 07'th May 2020

Alkermes Announces Upcoming Presentation at the Bank of America Securities Virtual Health Care Conference

 08:00pm, Wednesday, 06'th May 2020
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 2020 Bank of America Securities Virtual Health Care Conference on Wednesday, May 13, 2020 at 9:40

Johnston Asset Management Corp Buys Boston Scientific Corp, Albemarle Corp, Prologis Inc, Sells ...

 12:00am, Monday, 04'th May 2020

Analysts Have Lowered Expectations For Alkermes plc (NASDAQ:ALKS) After Its Latest Results

 01:45pm, Friday, 01'st May 2020
Alkermes plc (NASDAQ:ALKS) just released its first-quarter report and things are looking bullish. Revenues and losses...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE